Medindia

X

Promising Drug For Kidney Failure Fails in Large Clinical Trial‎

by VR Sreeraman on  October 28, 2011 at 3:48 PM Clinical Trials News   - G J E 4
A drug known as sulodexide has failed to show any benefit toward halting kidney failure in people with diabetes and an international trial has been stopped early, a US medical journal said Thursday.
 Promising Drug For Kidney Failure Fails in Large Clinical Trial‎
Promising Drug For Kidney Failure Fails in Large Clinical Trial‎
Advertisement

The drug, once seen as a potentially promising treatment to reduce protein in the urine, is made by New York-based Keryx Biopharmaceuticals, which also funded the study that was meant to include more than 2,240 patients worldwide.

Advertisement
However, it was halted after 1,248 people enrolled because there was no difference seen in preventing kidney failure between patients who took sulodexide over a placebo, said the report in the Journal of the American Society of Nephrology.

The study was led by David Packham of the Melbourne Renal Research Group in Australia.

Given the latest results and a smaller study that ran previously, "it is tempting to conclude that sulodexide has no therapeutic benefit in type 2 diabetic nephropathy," the authors wrote.

Kidney disease is common in people with diabetes because high blood sugar can cause the organs to get overworked and eventually fail.

Cases of kidney disease are expected to rise globally in the coming years in parallel with diabetes, which is expected to affect 366 million people by 2030, researchers said.

Source: AFP
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All